USPTO serial 79436858
HYDAPTOR
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- TMO LAW OFFICE 122
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with HYDAPTOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lauren K. Tagarao
Lauren K. Tagarao Renner, Otto, Boisselle & Sklar, LLP1621 Euclid AvenueFloor 19Cleveland, OH 44115Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; pharmaceuticals, medical and veterinary preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; biological preparations for medical purposes, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; biological preparations for medical purposes, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; biological preparations for veterinary purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; chemical preparations for medical purposes, namely, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; chemical preparations for pharmaceutical purposes, namely, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; diagnostic preparations for medical purposes; drugs for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; a full line of pharmaceuticals for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastrointestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose, vaccines, medicines for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastrointestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose, biologics in the nature of nucleic acids, proteins, or cells for the prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastrointestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose, biotherapeutics being nucleic acids, proteins, radiopharmaceuticals, or cells for the prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastrointestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose, biosimilars being biological medicines for the prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastrointestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose and therapeutics being nucleic acids, proteins, radiopharmaceuticals, or cells nucleic acids, proteins, or cells for the prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastrointestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose | ACTIVE | — |
| 009 | Downloadable software relating to healthcare, namely, for disease management; downloadable software for management of health and disease; downloadable software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; downloadable software for creating, managing, analyzing, and processing data related to research, development, and manufacturing of pharmaceutical and biopharmaceutical preparations for use in the fields of healthcare, disease management; downloadable software for controlling, optimization, calibration, maintenance, diagnostics, and troubleshooting of bioprocess systems, equipments, tools, and apparatus, namely, mixing devices, microfluidic devices, micro-mixing devices, mixing vessels, filtration systems, fermenters or bioreactors, liquid handling systems, separation systems, purification systems, chromatography systems, formulation systems, analytical systems, characterization systems, filling system, lyophilisation system, spray drying system, encapsulation system, pumps, pressure vessels, sensors, actuators, flow controllers, control system for fluidics, automated control systems, robotic systems, synthesis systems, and thermocyclers; downloadable software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, analytical characterization, immunological assays, and neutralization assays for production or manufacturing of pharmaceutical and biopharmaceutical preparations for use in the fields of healthcare, disease management; pre-recorded audio-visual or multimedia products in the nature of cassettes, audiotapes, videotapes, cds, dvds, cd-roms, optical discs, and portable storage devices being USB flash drives, external hard disk drives, external solid state drives, memory cards featuring scientific, medicinal, and pharmaceutical information in the field of healthcare, disease management, pharmaceuticals and medical developments; downloadable podcasts in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics and biosimilars | ACTIVE | — |
| 042 | Biological research; medical research; scientific laboratory services; scientific research; chemical research; research and development of new products for others; technological research in the field of biopharmaceuticals and pharmaceutical research, development, and manufacturing processes; scientific, medical, biological research and development in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; conducting clinical trials for others and testing services in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; engineering services relating to research and development of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; software as a service (SaaS) services featuring computer software for data mining, statistical analysis, data visualization of molecular structures, drug formulations, genomics data, clinical trial data, and medical records; creation of websites for others featuring information in the pharmaceutical, medical and health fields; hosting of a website featuring information in the pharmaceutical, medical and health fields; hosting podcasts being websites on the Internet featuring podcasts of others in the fields of pharmaceuticals, medical and health; software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; software as a service (Saas) services featuring computer software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, and analytical characterization for production or manufacturing of pharmaceutical and biopharmaceutical preparations, data management, or clinical trial management | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 9, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 9, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 17, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 17, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 17, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 20, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 20, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 4, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 3, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 13, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |